Friday, July 10, 2026

biotech · Propionic Acidemia · Isolated Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase Deficiency

SOM Biotech

SOM Biotech patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Barcelona, ES HQ
2009 Founded
14 Employees
EMA registrant Type
Company details
Intelligence · Patents

SOM Biotech patents

0 pharmaceutical patents indexed for SOM Biotech. 0 expire within 24 months.

SOM Biotech has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

No patents matched

Try a different expiry filter or check back as we index more USPTO records.

Frequently asked questions

How many patents does SOM Biotech have?

0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do SOM Biotech patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.